Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vadas

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
The American Journal of Pathology|April 1, 1989
The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2P Vadas, W Pruzanski, J Kim, et al.
Inflammation|April 1, 1991
Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytesW Pruzanski, S Saito, E Stefanski, et al.
The Journal of Rheumatology. Supplement|February 1, 1991
The role of phospholipase A2 in the physiopathology of osteoarthritisW Pruzanski, E Bogoch, M Wloch, et al.
The Journal of Rheumatology|April 1, 1985
Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzymeW Pruzanski, P Vadas, E Stefanski, et al.
Biochemical Pharmacology|June 15, 1997
Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activityW Pruzanski, E Stefanski, P Vadas, et al.
The Journal of Rheumatology|October 1, 1995
Induction of TNF-alpha and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritisW Pruzanski, M B Urowitz, B Grouix, et al.
The Journal of Rheumatology|January 1, 1988
Phospholipase A2 activity associated with synovial fluid cellsW Pruzanski, P Vadas, J Kim, et al.
Nature|October 15, 1981
Extracellular phospholipase A2 mediates inflammatory hyperaemiaP Vadas, S Wasi, H Z Movat, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1979
A novel, vasoactive product and plasminogen activator from afferent lymph cells draining chronic inflammatory lesionsP Vadas, S Wasi, H Z Movat, et al.
Infection and Immunity|September 1, 1992
Induction of circulating group II phospholipase A2 expression in adults with malariaP Vadas, J Keystone, E Stefanski, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|April 1, 1989
The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2P Vadas, W Pruzanski, J Kim, et al.
Inflammation|April 1, 1991
Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytesW Pruzanski, S Saito, E Stefanski, et al.
The Journal of Rheumatology. Supplement|February 1, 1991
The role of phospholipase A2 in the physiopathology of osteoarthritisW Pruzanski, E Bogoch, M Wloch, et al.
The Journal of Rheumatology|April 1, 1985
Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzymeW Pruzanski, P Vadas, E Stefanski, et al.
Biochemical Pharmacology|June 15, 1997
Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activityW Pruzanski, E Stefanski, P Vadas, et al.
The Journal of Rheumatology|October 1, 1995
Induction of TNF-alpha and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritisW Pruzanski, M B Urowitz, B Grouix, et al.
The Journal of Rheumatology|January 1, 1988
Phospholipase A2 activity associated with synovial fluid cellsW Pruzanski, P Vadas, J Kim, et al.
Nature|October 15, 1981
Extracellular phospholipase A2 mediates inflammatory hyperaemiaP Vadas, S Wasi, H Z Movat, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1979
A novel, vasoactive product and plasminogen activator from afferent lymph cells draining chronic inflammatory lesionsP Vadas, S Wasi, H Z Movat, et al.
Infection and Immunity|September 1, 1992
Induction of circulating group II phospholipase A2 expression in adults with malariaP Vadas, J Keystone, E Stefanski, et al.
Pageof 10